Boothbay Fund Management, LLC Syndax Pharmaceuticals Inc Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $5,866 - $8,795	404 Added 0.53%	76,909 $1.12 Million
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $1.48 Million - $1.71 Million	76,505 New	76,505 $1.6 Million
Q1 2021 May 17, 2021	SELL	$19.28 - $24.59 $295,446 - $376,817	-15,324 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$15.1 - $26.44 $231,392 - $405,166	15,324 New	15,324 $341,000
Q4 2018 Feb 14, 2019	SELL	$3.6 - $8.42 $36,000 - $84,200	-10,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.33 - $8.08 $63,300 - $80,800	10,000 New	10,000 $81,000

227

88.3M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $902M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.